Viewing Study NCT01131351


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-01-25 @ 8:57 AM
Study NCT ID: NCT01131351
Status: TERMINATED
Last Update Posted: 2021-11-11
First Post: 2010-05-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tuberculosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDR-TB View
None Dose Escalation View
None Phase II View
None Open Label View
None Non Controlled View
None Pulmonary Multidrug-Resistant Tuberculosis (MDR TB) View